Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CDH2 (clone hu2EA9Q). We employs the pAS (CMV-GFP-c-Fos-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CDH2
Clone
hu2EA9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pAS
Transformation Accuracy
0.94
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.